» Articles » PMID: 8862594

Rapid Detection of Point Mutations of the Neisseria Gonorrhoeae GyrA Gene Associated with Decreased Susceptibilities to Quinolones

Overview
Specialty Microbiology
Date 1996 Sep 1
PMID 8862594
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the gyrA gene resulting in amino acid changes at Ser-91 and Asp-95 are significantly associated with decreased susceptibilities to quinolones in Neisseria gonorrhoeae. To detect these mutations, we developed a rapid and simple assay based on amplification of the region of the gyrA gene containing the mutation sites by PCR and digestion of the PCR product with a restriction enzyme. A naturally occurring HinfI restriction site was present in the region containing the Ser-91 codon, and an artificial HinfI restriction site was created in the region containing the Asp-95 codon by the method of primer-specified restriction site modification. The mutations generating alterations at Ser-91 and Asp-95 were detected as restriction fragment length polymorphisms of the PCR products digested with HinfI. Fifty-five clinical strains of N. gonorrhoeae were examined for mutations in the gyrA gene by this method. Mutations at Ser-91 and/or Asp-95 were detected in all the 31 strains in which the mutations had been confirmed by DNA sequencing. Our method allows simultaneous testing of a large number of strains and provides results within 8 h. This rapid and simple assay could be a useful screening device for genetic alterations associated with decreased susceptibilities to quinolones in N. gonorrhoeae and could facilitate epidemiological studies on clinical isolates of N. gonorrhoeae with decreased susceptibilities to quinolones.

Citing Articles

Antibiograms and randomly amplified polymorphic DNA-polymerase chain reactions (RAPD-PCR) as epidemiological markers of gonorrhea.

Lawung R, Charoenwatanachokchai A, Cherdtrakulkiat R, Thammapiwan S, Mungniponpan T, Bulow L J Clin Lab Anal. 2010; 24(1):31-7.

PMID: 20087948 PMC: 6647703. DOI: 10.1002/jcla.20355.


Rapid detection of a point mutation in the parC gene associated with decreased susceptibility to fluoroquinolones in Mycoplasma bovis.

Lysnyansky I, Mikula I, Gerchman I, Levisohn S Antimicrob Agents Chemother. 2009; 53(11):4911-4.

PMID: 19721062 PMC: 2772355. DOI: 10.1128/AAC.00703-09.


Use of applied biosystems 7900HT sequence detection system and Taqman assay for detection of quinolone-resistant Neisseria gonorrhoeae.

Giles J, Hardick J, Yuenger J, Dan M, Reich K, Zenilman J J Clin Microbiol. 2004; 42(7):3281-3.

PMID: 15243093 PMC: 446300. DOI: 10.1128/JCM.42.7.3281-3283.2004.


Comparison of mismatch amplification mutation assay with DNA sequencing for characterization of fluoroquinolone resistance in Neisseria gonorrhoeae.

Sultan Z, Nahar S, Wretlind B, Lindback E, Rahman M J Clin Microbiol. 2004; 42(2):591-4.

PMID: 14766821 PMC: 344476. DOI: 10.1128/JCM.42.2.591-594.2004.


Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.

Chaudhry U, Ray K, Bala M, Saluja D Sex Transm Infect. 2002; 78(6):440-4.

PMID: 12473806 PMC: 1758340. DOI: 10.1136/sti.78.6.440.


References
1.
JEPHCOTT A, Turner A . Ciprofloxacin resistance in gonococci. Lancet. 1990; 335(8682):165. DOI: 10.1016/0140-6736(90)90035-4. View

2.
Gransden W, Warren C, Phillips I, Hodges M, Barlow D . Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet. 1990; 335(8680):51. DOI: 10.1016/0140-6736(90)90177-7. View

3.
Sreedharan S, Oram M, Jensen B, Peterson L, Fisher L . DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J Bacteriol. 1990; 172(12):7260-2. PMC: 210851. DOI: 10.1128/jb.172.12.7260-7262.1990. View

4.
Hooper D, Wolfson J . Fluoroquinolone antimicrobial agents. N Engl J Med. 1991; 324(6):384-94. DOI: 10.1056/NEJM199102073240606. View

5.
Stein D, Danaher R, Cook T . Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1991; 35(4):622-6. PMC: 245069. DOI: 10.1128/AAC.35.4.622. View